<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Paresh G. Koli</style></author><author><style face="normal" font="default" size="100%">Yashashri Shetty</style></author><author><style face="normal" font="default" size="100%">Reetu Sharma</style></author><author><style face="normal" font="default" size="100%">Bal Krishan Sevatkar</style></author><author><style face="normal" font="default" size="100%">Anaya A. Pathrikar</style></author><author><style face="normal" font="default" size="100%">Hemant S. Paradkar</style></author><author><style face="normal" font="default" size="100%">Mukesh B Chawda</style></author><author><style face="normal" font="default" size="100%">Sangam S. Narvekar</style></author><author><style face="normal" font="default" size="100%">Megha L. Nalawade</style></author><author><style face="normal" font="default" size="100%">Pawankumar R. Godatwar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">A Prospective, Multi-centre, Open label, Single arm Study to Evaluate the Efficacy and Safety of Amlapitta Mishran Suspension in Participants with Amlapitta (Symptomatic Gastritis)</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Ayurveda</style></keyword><keyword><style  face="normal" font="default" size="100%">Gastritis</style></keyword><keyword><style  face="normal" font="default" size="100%">Symptom scores</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">545-551</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;The multi-center clinical study was conducted to revalidate the efficacy and safety of Amlapitta Mishran Suspension in Amlapitta (symptomatic gastritis) in a larger sample size in improving Amlapitta Symptom Rating Scale Score, PPDS score, EPS score, and safety. &lt;strong&gt;Methods: &lt;/strong&gt;The study was a multi-centric, open-labeled, single-arm, prospective clinical trial in participants with Amlapitta (symptomatic gastritis). Participants with the presence of Amlapitta (symptomatic gastritis), as diagnosed by the Amlapitta Symptom Rating Scale Score ≥ 5 were included in the study. Participants were advised to take Amlapitta Mishran Suspension in a dose of 15 ml twice daily for 14 days. The study involved three visits. The investigator recorded the Amlapitta Symptom Rating Scale (ASRS) Score, Post Prandial Distress Syndrome (PPDS) Score, and Epigastric Pain Syndrome (EPS) Score at screening visit (Visit 1), baseline visit (Visit 2) and final visit (Visit 3). The p&amp;lt;0.05 was considered statistically significant measured by paired t-test or Wilcoxon Signed Rank test. &lt;strong&gt;Results: &lt;/strong&gt;In the multi-center study 204 participants completed the study. At final visit, a statistically significant (p&amp;lt;0.001) reduction was reported in mean Total ASRS score, PPDS score, and EPS score as compared to the baseline scores. The individual ASRS, PPDS, and EPS variables also exhibited significant reduction (p&amp;lt;0.001) at the final visit. None of the participants reported any adverse events during the study. &lt;strong&gt;Conclusion: &lt;/strong&gt;Amlapitta Mishran Suspension treatment for 14 days effectively and safely reduced the clinical symptoms of Amlapitta (symptomatic gastritis) assessed by Amlapitta Symptom Rating Scale, Postprandial Distress Syndrome and Epigastric Pain Syndrome scores.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">545</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Paresh G. Koli&lt;sup&gt;1*,&lt;/sup&gt; Yashashri Shetty&lt;sup&gt;1&lt;/sup&gt;, Reetu Sharma&lt;sup&gt;2&lt;/sup&gt;, Bal Krishan Sevatkar&lt;sup&gt;2&lt;/sup&gt;, Anaya A. Pathrikar&lt;sup&gt;3&lt;/sup&gt;, Hemant S. Paradkar&lt;sup&gt;3&lt;/sup&gt;, Mukesh B Chawda&lt;sup&gt;4&lt;/sup&gt;, Sangam S. Narvekar&lt;sup&gt;5&lt;/sup&gt;, Megha L. Nalawade&lt;sup&gt;6&lt;/sup&gt;, Pawankumar R. Godatwar&lt;sup&gt;7&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology and Therapeutics, Seth GS Medical College and KEM Hospital, Mumbai. INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Roga Nidana Evum Vikriti Vigyana, National Institute of Ayurveda, Madhav Vilas Palace, Jorawar Singh Gate Amer Road, Jaipur - 302 002. INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Kayachikitsa, Ayurvidya Prasarak Mandal’s, Seth R.V. Ayurvedic Hospital, Sion (E), Mumbai - 400 022. INDIA&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Medical Services, Solumiks Herbaceuticals Limited, 135, Nanubhai Desai Road, Khetwadi, Mumbai - 400 004. INDIA&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Medical Services, Shree Dhootapapeshwar Limited, 135, Nanubhai Desai Road, Khetwadi, Mumbai – 400 004. INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Shree Dhootapapeshwar Limited, 135, Nanubhai Desai Road, Khetwadi, Mumbai - 400 004. INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;7&lt;/sup&gt;Department of Roga Nidana Evum Vikriti Vigyana, National Institute of Ayurveda, Madhav Vilas Palace, Jorawar Singh Gate, Amer Road Jaipur - 302 002. INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nandakumar K N</style></author><author><style face="normal" font="default" size="100%">Mohanraj Nehru</style></author><author><style face="normal" font="default" size="100%">Prasanth Subramanian</style></author><author><style face="normal" font="default" size="100%">Bhuvaneshwaran Mothiswaran</style></author><author><style face="normal" font="default" size="100%">Vishagan S S</style></author><author><style face="normal" font="default" size="100%">Satishkumar Rajappan Chandra</style></author><author><style face="normal" font="default" size="100%">Venkataraman Prabhu</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Potential Molecular level Impact of Cresvin beta on Type 2 Diabetes Mellitus: A Randomized Controlled Clinical Trial</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">anti-diabetic efficacy</style></keyword><keyword><style  face="normal" font="default" size="100%">Ayurveda</style></keyword><keyword><style  face="normal" font="default" size="100%">Cresvin beta</style></keyword><keyword><style  face="normal" font="default" size="100%">Metformin</style></keyword><keyword><style  face="normal" font="default" size="100%">Sirtuin 1</style></keyword><keyword><style  face="normal" font="default" size="100%">Type 2 diabetes mellitus</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1297-1304</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with an increasing prevalence rate over the past few decades. Despite the availability of medications to prevent and reduce disease severity, T2DM prevalence and incidence continue to rise annually. Understanding genetic heritage's impact on therapeutic responses is improving, with pharmacogenetics being used to better comprehend the therapeutic variability of T2DM. This study aims to compare the effects of metformin and Cresvin beta capsules containing Pterocarpus marsupium, Withania somnifera, Salacia reticulata, Gymnema Sylvestre, Curcuma longa, Vitis vinifera and Piper nigrum (Black pepper extract) on diabetic and immune-related gene expression in T2DM patients. &lt;strong&gt;Methods:&lt;/strong&gt; Sixty patients were divided into two groups: metformintreated (group A, n=30) and Cresvin beta -treated (group B, n=30). Anthropometric, biochemical, and hematological parameters were measured at baseline and after 3 months of treatment. Gene expression levels were analyzed using quantitative real-time polymerase chain from DNA extracted from whole blood samples.&lt;strong&gt; Results:&lt;/strong&gt; After 3 months, metformin significantly reduced fasting blood sugar (FBS), postprandial blood sugar (PPBS), and HbA1c levels (p&amp;lt;0.001). Cresvin beta also significantly reduced FBS (p&amp;lt;0.01), PPBS (p&amp;lt;0.001), and HbA1c (p&amp;lt;0.001). Gene expression analysis showed significant changes in SIRT1, AKT, SLC2A4, IL-6, and TNF-α in both groups. &lt;strong&gt;Conclusion: &lt;/strong&gt;The study demonstrated that Cresvin beta reduced glycemic levels and improved SIRT1, Pi3k, Akt, and SLC2A4 gene expression while decreasing IL-6 and TNF-α cytokine gene expression in T2DM patients.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1297</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Nandakumar K N&lt;sup&gt;1&lt;/sup&gt;, Mohanraj Nehru&lt;sup&gt;1&lt;/sup&gt;, Prasanth Subramanian&lt;sup&gt;1&lt;/sup&gt;, Bhuvaneshwaran Mothiswaran&lt;sup&gt;2&lt;/sup&gt;, Vishagan S S&lt;sup&gt;3&lt;/sup&gt;, Satishkumar Rajappan Chandra&lt;sup&gt;2&lt;/sup&gt;, Venkataraman Prabhu&lt;sup&gt;1,*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Medical Research, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Chennai, Tamilnadu, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Clinical Trial and Research Unit, Interdisciplinary Institute of Indian System of Medicine, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Chennai, Tamilnadu, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Director of Apex Laboratories Pvt Ltd, Chennai, Tamilnadu, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sujithra M</style></author><author><style face="normal" font="default" size="100%">Vimala KS</style></author><author><style face="normal" font="default" size="100%">Sabitha M</style></author><author><style face="normal" font="default" size="100%">Priya S</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">An Analytical and in-vivo Study to Evaluate the Effect of Triphala Kaṣāya Vāsita Godhūma (Triticum aestivum grains soaked in Triphala Kaṣāya) on its Glycemic Index compared to Raw Godhūma (Raw Triticum aestivum grains)</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Ayurveda</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes</style></keyword><keyword><style  face="normal" font="default" size="100%">Gluten</style></keyword><keyword><style  face="normal" font="default" size="100%">Glycemic index</style></keyword><keyword><style  face="normal" font="default" size="100%">Godhūma</style></keyword><keyword><style  face="normal" font="default" size="100%">Prameha</style></keyword><keyword><style  face="normal" font="default" size="100%">Triphala kaṣāya</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">May 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">526-534</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Diabetes is generally referred to as a Metabolic Disorder or a Lifestyle Disorder, that is mainly characterized by the symptom of Hyperglycemia caused by the defective insulin secretion, congenital or acquired. Diabetes requires management of diet and lifestyle with or without medications to keep the blood sugar under control. Foods with medium Glycemic Index (GI) is best preferred for Diabetics, because high GI foods will rapidly increase the blood sugar level, and low GI will cause grave health issues. In practice, wheat is the highly recommended diet for diabetics as the GI is medium in comparison to rice that belongs to a high GI group. But wheat causes digestive problems, and flatulence in addition to the Gluten allergy that many people suffer from. However in Āyurveda, the Classical Text Aṣṭāṅga Hṛdaya (AH) mentions in Prameha Cikitsa Adhyāya (Chapter on Treatment of Diabetes) that Godhūma (grains of Wheat - Triticum aestivum L) has to be kept soaked in Triphala Kaṣāya (Decoction prepared with the fruits of Terminalia chebula, T. bellerica and Phyllanthus emblica) and then dried and powdered before being used as a diet for a diabetic. The grains of Godhūma were kept soaked in Triphala Kaṣāya and then dried and powdered. A comparative analytical study was done for the two samples- treated wheat grains (Triphala Kaṣāya Vāsita Godhūma) and untreated/raw wheat grains. An In vivo study was also done to assess the GI value of both the samples of wheat. The analytical and In vivo study results prove that while the GI is still maintained within medium range, the allergen gluten is completely eliminated, total fat and total protein have reduced while still maintaining the nutritive value, in the treated sample when compared to the raw sample. Based on the results obtained from the analytical and in-vivo study, it can be concluded that Triphala Kaṣāya Vāsita Godhūma becomes even more compatible and healthy for a diabetic, in gluten allergy and discomforts caused by wheat consumption, in comparison to the untreated wheat grains.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">526</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Sujithra M&lt;sup&gt;1,&lt;/sup&gt;*, Vimala KS&lt;sup&gt;2&lt;/sup&gt;, Sabitha M&lt;sup&gt;3&lt;/sup&gt;, Priya S&lt;sup&gt;4 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;PG Scholar, Department of Dravya Guna Vijnana (Ayurvedic Pharmacology), Amrita School of Ayurveda, Amritapuri; Amrita Vishwa Vidyapeetham, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Professor, Department of Dravya Guna Vijnana (Ayurvedic Pharmacology), Amrita School of Ayurveda, Amritapuri; Amrita Vishwa Vidyapeetham, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Principal, Amrita School of Pharmacy, Cochin; Amrita Vishwa Vidyapeetham, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;HOD &amp;amp; Professor, Department of Dravya Guna Vijnana (Ayurvedic Pharmacology), Amrita School of Ayurveda, Amritapuri; Amrita Vishwa Vidyapeetham, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sujithra Ram Manohar</style></author><author><style face="normal" font="default" size="100%">Vimala</style></author><author><style face="normal" font="default" size="100%">Priyalatha</style></author><author><style face="normal" font="default" size="100%">Raiby Paul</style></author><author><style face="normal" font="default" size="100%">Priya S</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">A Brief Review of Synonyms and Properties of Gudūcī (Tinospora cordifolia (Thunb.) Miers) from Selected Nighantus (Ayurvedic Drug Lexicons)</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Ayurveda</style></keyword><keyword><style  face="normal" font="default" size="100%">Guduci</style></keyword><keyword><style  face="normal" font="default" size="100%">Nighantus</style></keyword><keyword><style  face="normal" font="default" size="100%">Properties</style></keyword><keyword><style  face="normal" font="default" size="100%">Synonyms</style></keyword><keyword><style  face="normal" font="default" size="100%">Tinopsora cordifolia</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2018</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">s9-s13</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;The use of Herbal medicines are continuously on the rise as they are known to be very efficient without causing much undesired effects. Herbs are the main source for Traditional Chinese Medicine and Persian and extensive literature and scientific research is being done in this aspect. Ethnobotanical studies are being conducted in specific areas to understand and analyse the relative priority, agreement percentage and the use value. Phytochemical and Pharmacological Tests are also carried out to substantiate the use.&lt;sup&gt;1&lt;/sup&gt; Plant toxins and plant poisoning have been reported in children.&lt;sup&gt;2&lt;/sup&gt; Unfortunately, though herbs are generally considered to be safe, it does contain chemical constituents that can be helpful or harmful when consumed individually or in combination with other herbs or drugs. For more and more scientific studies to come up, the basic literature review has to be done.&lt;em&gt; Ayurveda&lt;/em&gt; is an Ancient System of Medicine practiced in India since centuries. The practice is based on Classical Ayurvedic Texts and the &lt;em&gt;Nighantus&lt;/em&gt; that came in the later period. In this article, Guduci- Tinospora cordifolia (Tco) - a commonly used plant in &lt;em&gt;Ayurveda&lt;/em&gt; that holds a great medicinal value.&lt;sup&gt;3&lt;/sup&gt; has been chosen and the review of the Synonyms and Properties of this plant mentioned in selected &lt;em&gt;Nighantus&lt;/em&gt; has been done. The different properties of the plant like anti hyperglycemic action, antioxidant, hepato-protective activity, etc have already been researched and proven.&lt;sup&gt;4&lt;/sup&gt; Retrospectively, here a comparative analysis of synonyms and properties of Tco as mentioned in the &lt;em&gt;Nighantu&amp;rsquo;s&lt;/em&gt; from the Ayurvedic Point of view has been done.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">s9</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Sujithra Ram Manohar&lt;sup&gt;*&lt;/sup&gt;, Vimala, Priyalatha, Raiby Paul, Priya S&lt;sup&gt;*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Department of Dravya Guna (Ayurvedic Pharmacology), Amrita School of Ayurveda, Amritapuri, Amrita Vishwa Vidyapeetham, Kerala, INDIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Venkata Siva Satyanarayana Kantamreddi</style></author><author><style face="normal" font="default" size="100%">V. Thirumala Veni</style></author><author><style face="normal" font="default" size="100%">G. Y. S. K. Swamy</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">A Quantitative Approach to Estimate both Essential and Non-essential Elements in Some Commercial Samples of Triphala churna by using WD-XRF Spectrometry</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Ayurveda</style></keyword><keyword><style  face="normal" font="default" size="100%">Elemental analysis</style></keyword><keyword><style  face="normal" font="default" size="100%">ICP-MS</style></keyword><keyword><style  face="normal" font="default" size="100%">ISM</style></keyword><keyword><style  face="normal" font="default" size="100%">Triphala churna</style></keyword><keyword><style  face="normal" font="default" size="100%">WD-XRF</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2017 </style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">/files/PJ-9-3/10.5530pj.2017.3.64</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">9</style></volume><pages><style face="normal" font="default" size="100%">378-381</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; The need for quality control of herbal drugs is in demand in order to ensure the purity, safety and efficacy of herbal products. A total of 19 elements including essential and non-essential elements were characterized in five commercial samples of &lt;em&gt;Triphala churna&lt;/em&gt; using WD-XRF spectrometry. &lt;strong&gt;Method:&lt;/strong&gt; The WD-XRF method was validated for each element by a pre-calibrated program using five Chinese certified reference materials of vegetable standards (NCS ZC73012, NCS ZC73013, NCS ZC73017, NCS ZC85006 and NCS DC73348). &lt;strong&gt;Results:&lt;/strong&gt; The following elements were detected in all the samples out of 19 elements tested with increasing order of concentrations (mg/kg): Cr (3) &amp;lt; Cu (7) &amp;lt; Ba (24) &amp;lt; Zn (31) &amp;lt; Pb (46) &amp;lt; Mn (57) &amp;lt; S (700) &amp;lt; Na (1064) &amp;lt; Mg (1250) &amp;lt; Fe (1329) &amp;lt; P (1400) &amp;lt; Cl (2960) &amp;lt; Ca (3110) &amp;lt; Si (4350) &amp;lt; K (15130). Lead (41-46 mg/kg), a nonessential element was found above its PDE limit (&amp;le; 10 mg/kg). &lt;strong&gt;Conclusion:&lt;/strong&gt; WD-XRF method was found simple, rapid, reliable and non-destructive technique to investigate the elemental concentrations in herbal drugs.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">378</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Venkata Siva Satyanarayana Kantamreddi&lt;sup&gt;1*&lt;/sup&gt;, V. Thirumala Veni&lt;sup&gt;1&lt;/sup&gt; and G. Y. S. K. Swamy&lt;sup&gt;2 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Centre for Chemical Analysis, Central Research Laboratory, GIT, GITAM University, Visakhapatnam, Andhra Pradesh, INDIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Laboratory of X-ray Crystallography, Indian Institute of Chemical Technology, CSIR, Hyderabad, Telangana, INDIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Reena Kulkarni</style></author><author><style face="normal" font="default" size="100%">Suhas Kumar Shetty</style></author><author><style face="normal" font="default" size="100%">Rajarajeshwari N M</style></author><author><style face="normal" font="default" size="100%">Prasanna Narasimha Rao</style></author><author><style face="normal" font="default" size="100%">Nayan J</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Rasayana Herbs of Ayurveda to Treat age Related Cognitive Decline: An Update</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Ayurveda</style></keyword><keyword><style  face="normal" font="default" size="100%">cognitive decline</style></keyword><keyword><style  face="normal" font="default" size="100%">Dementia</style></keyword><keyword><style  face="normal" font="default" size="100%">Herbs</style></keyword><keyword><style  face="normal" font="default" size="100%">Medhya</style></keyword><keyword><style  face="normal" font="default" size="100%">Rasayana.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">Oct 2016</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">8</style></volume><pages><style face="normal" font="default" size="100%">411-423</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Cognitive decline associated with aging could be minor or major neuro-cognitive disorder presenting with progressive intellectual deterioration interfering with day to day activities. Behaviour and personality changes may complicate the life in due course. Significant increase in global prevalence of people aged above 60 years has raised concerns on effective management of old age problems. Age related cognitive deficits and dementia raise to the level of epidemics and established management is yet underway. Principles of preventive health and rasayana (rejuvenative) herbs of Ayurveda are being extensively researched up on for their effectiveness in dementia. In this fourteen such herbs with anti dementia property are discussed with relevant research update. &lt;strong&gt;Methods:&lt;/strong&gt; Herbs like amalaki (&lt;em&gt;Emblica officinalis&lt;/em&gt;), hareetaki (&lt;em&gt;Terminalia chebula&lt;/em&gt;), haridra (&lt;em&gt;Curcuma longa&lt;/em&gt;), manduka parni (&lt;em&gt;Centella asiatica&lt;/em&gt;), aindri (&lt;em&gt;Bacopa monniera&lt;/em&gt;), yastimadhu (&lt;em&gt;Glycirrhiza glabra&lt;/em&gt;), guduchi (&lt;em&gt;Tinospora cordifolia&lt;/em&gt;), shankhapushpi (&lt;em&gt;Convolvulus pleuricaulis&lt;/em&gt;), vacha (&lt;em&gt;Acorus calamus&lt;/em&gt;), jyotishmati (&lt;em&gt;Celastrus panniculata&lt;/em&gt;), kushmanda (&lt;em&gt;Benincasa hispida&lt;/em&gt;), Jatamamsi (&lt;em&gt;Nardostachys jatamamsi&lt;/em&gt;), ashvagandha (&lt;em&gt;Withania somnifera&lt;/em&gt;) and kapikacchu (&lt;em&gt;Mucuna pruriens&lt;/em&gt; (&lt;em&gt;Linn&lt;/em&gt;.)) are already proven of their efficacy in experimental and preclinical levels. The contents and research evidences are collected from ayurveda database on medicinal plants used in Ayurveda and Siddha and other authentic literature, Google scholar, Science direct, online and print journals. &lt;strong&gt;Discussion:&lt;/strong&gt; The herbs in discussion mostly act on reactive oxygen species and oxidative stress injury by antioxidant properties and neuroprotective activity. Acetylcholine esterase inhibition, N-Methyl-D-Aspartate antagonism, Dopaminergic activity, Anti-amyloidogenic activity, Inhibition of Tau aggregation, neuroprotection and immune modulation are activity path ways. Tridosha namely Kapha, Pitta and Vata may be viewed to be categorically predominant in initial, middle and final stage of dementia. Selected herbs thus can be specific based on the pathology and relevant dosha predominance.&lt;strong&gt; Conclusion: &lt;/strong&gt;Rasayana herbs with current updates and inferences can serve as an eye-opener for further researches at molecular and clinical aspect.&lt;/p&gt;

</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">411</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Reena Kulkarni&lt;sup&gt;1*&lt;/sup&gt;, Suhas Kumar Shetty&lt;sup&gt;2&lt;/sup&gt;, Rajarajeshwari N M&lt;sup&gt;3&lt;/sup&gt;, Prasanna Narasimha Rao&lt;sup&gt;4&lt;/sup&gt; and Nayan J&lt;sup&gt;5 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Kaumarabhritya, SDM College of Ayurveda, Tanniruhalla, Hassan-INDIA.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Manasa Roga, SDM College of Ayurveda, Tanniruhalla, Hassan-INDIA.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Samhita and Siddhanta, SDM College of Ayurveda, Tanniruhalla, Hassan-INDIA.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Shalya Tantra, SDM College of Ayurveda, Tanniruhalla, Hassan-INDIA.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Department of Agada tantra, Sri Kalabairaveshvara Swamy Ayurveda Medical College, RPC layout, Vijayanagar, Bengaluru-40, Karnataka, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alpana Kulkarni</style></author><author><style face="normal" font="default" size="100%">Shreya Rumalla</style></author><author><style face="normal" font="default" size="100%">Swati Andhale</style></author><author><style face="normal" font="default" size="100%">Bhanudas Kuchekar</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Ajit Kolatkar</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Taste Masking of Ayurvedic Nutraceutical Formulation by Pan Coating Process</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Ayurveda</style></keyword><keyword><style  face="normal" font="default" size="100%">Coating</style></keyword><keyword><style  face="normal" font="default" size="100%">Eudragit E 100</style></keyword><keyword><style  face="normal" font="default" size="100%">Nutraceutical</style></keyword><keyword><style  face="normal" font="default" size="100%">Taste Masking</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">Jul-Aug 2015</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">7</style></volume><pages><style face="normal" font="default" size="100%">215-220</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Background:&lt;/strong&gt; Ayurvedic medicines and nutraceuticals are gaining popularity among physicians and patients for better therapeutic value. Lack of quality standards and problems, in preparing or testing them, are the main hurdles experienced by both the practitioners and the patients.&lt;strong&gt; Objective:&lt;/strong&gt; The objective of the study was to improve the palatability of the Ayurvedic Nutraceutical Preparation (ADS) by masking its bitter taste and to standardize the taste masking procedure. In the present study Eudragit E 100 was used as an acid soluble coating material. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; ADS powder was converted into granules with PVP K30 as a granulating agent and the ADS granules were coated with Eudragit E 100 coating solution by pan coating process. Various IPQC tests namely flow properties, moisture content were performed on the granules before and after coating for determination of endpoint of granulation and coating respectively. The ADS powder and granules were evaluated for bitter taste. &lt;strong&gt;Results:&lt;/strong&gt; ADS granules were advantageous over ADS powder since the flow properties of ADS granules were better than the flow properties of ADS powder, a prerequisite of pan coating process. Eudragit E 100 inhibited the contact in between the plant extracts and the taste buds due to insolubility of Eudragit E 100 in saliva. Sensory evaluation of taste indicated that the taste of coated granules was significantly masked.&lt;strong&gt; Conclusion: &lt;/strong&gt;The bitter taste of ADS was improved successfully with Eudragit E 100 as a coating agent and the pan coating process. An attempt was made to standardize the pan coating process.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">215</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Alpana Kulkarni&lt;sup&gt;*1&lt;/sup&gt;, Shreya Rumalla&lt;sup&gt;1&lt;/sup&gt;, Swati Andhale&lt;sup&gt;1&lt;/sup&gt;, Ajit Kolatkar&lt;sup&gt;2&lt;/sup&gt; and Bhanudas Kuchekar&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt; 1Department of Quality Assurance, MAEER&amp;rsquo;S Maharashtra Institute of Pharmacy, S. No. 124, MIT Campus, Paud Road, Kothrud, Pune-411038, Maharashtra, India 2Department of Integrative Science, Ayurved Consultant, Partner &amp;amp; Director, Arya Rasyan Bioresearch Labs LLP, Pune, Maharashtra, India.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">AlpanaKulkarni</style></author><author><style face="normal" font="default" size="100%">Shreya Rumalla</style></author><author><style face="normal" font="default" size="100%">Swati Andhale</style></author><author><style face="normal" font="default" size="100%">Ajit Kolatkar</style></author><author><style face="normal" font="default" size="100%">Bhanudas Kuchekar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Taste Masking of AyurvedicNutraceutical Formulation by Pan Coating Process</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Ayurveda</style></keyword><keyword><style  face="normal" font="default" size="100%">Coating</style></keyword><keyword><style  face="normal" font="default" size="100%">Eudragit E 100</style></keyword><keyword><style  face="normal" font="default" size="100%">Nutraceutical</style></keyword><keyword><style  face="normal" font="default" size="100%">Taste Masking.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">29th Apr, 2015</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">7</style></volume><pages><style face="normal" font="default" size="100%">215-220</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Ayurvedic medicines and nutraceuticals are gaining popularity among physicians and patients for better therapeutic value. Lack of quality standards and problems, in preparing or testing them, are the main hurdles experienced by both the practitioners and the patients. &lt;strong&gt;Objective: &lt;/strong&gt;The objective of the study was to improve the palatability of the Ayurvedic Nutraceutical Preparation (ADS) by masking its bitter taste and to standardize the taste masking procedure. In the present study Eudragit E 100 was used as an acid soluble coating material. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; ADS powder was converted into granules with PVP K30 as a granulating agent and the ADS granules were coated with Eudragit E 100 coating solution by pan coating process. Various IPQC tests namely flow properties, moisture content were performed on the granules before and after coating for determination of endpoint of granulation and coating respectively. The ADS powder and granules were evaluated for bitter taste. &lt;strong&gt;Results: &lt;/strong&gt;ADS granules were advantageous over ADS powder since the flow properties of ADS granules were better than the flow properties of ADS powder, a prerequisite of pan coating process. Eudragit E 100 inhibited the contact in between the plant extracts and the taste buds due to insolubility of Eudragit E 100 in saliva. Sensory evaluation of taste indicated that the taste of coated granules was significantly masked. &lt;strong&gt;Conclusion: &lt;/strong&gt;The bitter taste of ADS was improved successfully with Eudragit E 100 as a coating agent and the pan coating process. An attempt was made to standardize the pan coating process.&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Key words: &lt;/strong&gt;Ayurveda, Coating, Eudragit E 100, Nutraceutical, Taste Masking.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">215</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Alpana Kulkarni&lt;sup&gt;*1&lt;/sup&gt;, Shreya Rumalla&lt;sup&gt;1&lt;/sup&gt;, Swati Andhale&lt;sup&gt;1&lt;/sup&gt;, Ajit Kolatkar&lt;sup&gt;2&lt;/sup&gt; and Bhanudas Kuchekar&lt;sup&gt;1 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Quality Assurance, MAEER&amp;rsquo;S Maharashtra Institute of Pharmacy, S. No. 124, MIT Campus, Paud Road, Kothrud, Pune-411038, Maharashtra, India&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Integrative Science, Ayurved Consultant, Partner &amp;amp; Director, Arya Rasyan Bioresearch Labs LLP, Pune, Maharashtra, India.&lt;/p&gt;</style></auth-address></record></records></xml>